[SARS-CoV-2 uses different entry routes to infect host cells]

Med Sci (Paris). 2022 May;38(5):419-422. doi: 10.1051/medsci/2022048. Epub 2022 May 24.

[Article in French]

Authors

Jana Koch¹, Zina M Uckeley¹, Pierre-Yves Lozach²

Affiliations

¹ CellNetworks - Cluster of excellence and department of infectious diseases, virology, University Hospital Heidelberg, Heidelberg, Allemagne.
² CellNetworks - Cluster of excellence and department of infectious diseases, virology, University Hospital Heidelberg, Heidelberg, Allemagne - Univ. Lyon, INRAE, EPHE, IVPC, Lyon, France.

PMID: 35608461
DOI: 10.1051/medsci/2022048

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angiotensin-Converting Enzyme 2
COVID-19*
Humans
SARS-CoV-2*
Virus Internalization

Substances

Angiotensin-Converting Enzyme 2

Grants and funding